ENDRA Life Sciences Inc. — Director's Dealing 2019

Aug 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2019-08-22

Reporting Person: Wells David R. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-22	Common Stock	P	5000	$1.56	Acquired	5000	Direct
2019-08-23	Common Stock	P	5000	$1.55	Acquired	10000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	24786	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.59, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.